Johnson & Johnson (JNJ) Holdings Lifted by Franklin Street Advisors Inc. NC

Franklin Street Advisors Inc. NC boosted its holdings in shares of Johnson & Johnson (NYSE:JNJ) by 2.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 81,212 shares of the company’s stock after acquiring an additional 1,597 shares during the period. Johnson & Johnson makes up approximately 1.8% of Franklin Street Advisors Inc. NC’s investment portfolio, making the stock its 13th largest holding. Franklin Street Advisors Inc. NC’s holdings in Johnson & Johnson were worth $10,744,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Lenox Wealth Advisors Inc. lifted its holdings in Johnson & Johnson by 0.6% during the second quarter. Lenox Wealth Advisors Inc. now owns 876 shares of the company’s stock worth $116,000 after acquiring an additional 5 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. lifted its holdings in Johnson & Johnson by 241.0% during the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 1,190 shares of the company’s stock worth $149,000 after acquiring an additional 841 shares in the last quarter. Ullmann Financial Group Inc. bought a new position in Johnson & Johnson during the first quarter worth about $186,000. Taylor Wealth Management Partners lifted its holdings in Johnson & Johnson by 19.8% during the first quarter. Taylor Wealth Management Partners now owns 1,510 shares of the company’s stock worth $188,000 after acquiring an additional 250 shares in the last quarter. Finally, Hutchens Investment Management Inc bought a new position in Johnson & Johnson during the first quarter worth about $204,000. Hedge funds and other institutional investors own 65.90% of the company’s stock.

JNJ has been the topic of several recent analyst reports. UBS AG reiterated a “buy” rating and set a $148.00 target price (up from $136.00) on shares of Johnson & Johnson in a report on Wednesday, July 19th. Goldman Sachs Group, Inc. (The) lowered Johnson & Johnson from a “neutral” rating to a “sell” rating and lifted their target price for the stock from $125.00 to $130.00 in a report on Wednesday, September 20th. BMO Capital Markets reiterated a “buy” rating and set a $145.00 target price on shares of Johnson & Johnson in a report on Friday, September 1st. Alembic Global Advisors lowered Johnson & Johnson from a “neutral” rating to an “underweight” rating in a report on Friday, July 21st. Finally, BidaskClub upgraded Johnson & Johnson from a “buy” rating to a “strong-buy” rating in a report on Saturday, June 17th. Five analysts have rated the stock with a sell rating, eight have assigned a hold rating and ten have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $136.02.

Johnson & Johnson (NYSE:JNJ) traded up 0.14% during mid-day trading on Thursday, hitting $136.84. The company had a trading volume of 2,796,170 shares. The company’s 50 day moving average price is $132.32 and its 200-day moving average price is $130.07. The firm has a market capitalization of $367.28 billion, a PE ratio of 23.15 and a beta of 0.78. Johnson & Johnson has a 12-month low of $109.32 and a 12-month high of $137.52.

Johnson & Johnson (NYSE:JNJ) last posted its earnings results on Tuesday, July 18th. The company reported $1.83 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.79 by $0.04. Johnson & Johnson had a net margin of 22.52% and a return on equity of 26.76%. The firm had revenue of $18.84 billion for the quarter, compared to analysts’ expectations of $18.94 billion. During the same quarter last year, the firm earned $1.74 EPS. The company’s quarterly revenue was up 1.9% compared to the same quarter last year. On average, analysts forecast that Johnson & Johnson will post $7.18 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 12th. Shareholders of record on Tuesday, August 29th were given a dividend of $0.84 per share. The ex-dividend date of this dividend was Friday, August 25th. This represents a $3.36 annualized dividend and a dividend yield of 2.46%. Johnson & Johnson’s dividend payout ratio is currently 56.76%.

In other Johnson & Johnson news, VP Paulus Stoffels sold 102,692 shares of Johnson & Johnson stock in a transaction that occurred on Monday, July 24th. The shares were sold at an average price of $133.14, for a total transaction of $13,672,412.88. Following the transaction, the vice president now owns 230,342 shares of the company’s stock, valued at approximately $30,667,733.88. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, VP Dominic J. Caruso sold 82,591 shares of Johnson & Johnson stock in a transaction that occurred on Thursday, July 20th. The stock was sold at an average price of $136.72, for a total transaction of $11,291,841.52. Following the transaction, the vice president now directly owns 226,693 shares in the company, valued at approximately $30,993,466.96. The disclosure for this sale can be found here. 0.19% of the stock is owned by company insiders.

COPYRIGHT VIOLATION WARNING: This article was posted by Markets Daily and is the property of of Markets Daily. If you are reading this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright law. The original version of this article can be viewed at https://www.themarketsdaily.com/2017/10/12/johnson-johnson-jnj-holdings-lifted-by-franklin-street-advisors-inc-nc.html.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply